Navigation Links
Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
Date:10/15/2007

MADISON, Wis., Oct. 15 /PRNewswire/ -- Researchers at Baylor College of Medicine and Roche NimbleGen Inc., a fully integrated part of Roche Applied Science, today have published details of a highly efficient and cost-effective method for capturing targeted regions of the genome via NimbleChip(TM) microarrays in preparation for high-throughput 454 Sequencing(TM). The technology, called "sequence capture," enables fast and accurate enrichment of thousands of selected genomic regions, either contiguous or dispersed, such as segments of chromosomes or all genes or exons. The study, entitled "Direct Selection of Human Genomic Loci by Microarray Hybridization," appears online (ahead of print) in the journal Nature Methods(1).

In light of the success of the current sequence capture technology, Baylor's Human Genome Sequencing Center (HGSC) has signed on as an early access customer to Roche NimbleGen's sequence capture technology. As presented on October 10, 2007, at the J. Craig Venter Institute's Genomes, Medicine, and the Environment (GME) conference, Roche NimbleGen and 454 Life Sciences, working with Dr. Richard Gibbs, professor and Director of the HGSC, will create a whole-genome human exome (all exons) microarray, with the goal of resequencing the entire human exome.

Resequencing of genes or other genomic regions of interest is a key step in detecting mutations associated with various complex human diseases, such as cancer, asthma and heart disease. The predominant method for selection of specific genomic regions for resequencing has primarily relied on PCR (polymerase chain reaction) to enrich for specific DNA fragments. However, PCR is limited in the length of sequence it can amplify, is difficult to scale or multiplex for the enrichment of thousands of fragments, and has limited performance in the repetitive regions typical of complex genomes, such as human. The sequence capture microarray technology bridges the gap between next-generation DNA s
'/>"/>

SOURCE Roche NimbleGen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount System for Automated Cell Counting at AACR
2. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
3. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
4. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. Antisense Pharma: Promising Phase IIb Results of Targeted Therapy with AP 12009 in Recurrent Anaplastic Astrocytoma
7. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
8. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
9. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
10. News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
11. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Critical Double-Stranded DNA Repair Protein, Rad51
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... fiscal year 2015 financial results after the market close ... will follow on the same day at 4:30 p.m. ... and Chief Executive Officer, and Rick Eiswirth , ...
(Date:7/30/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... treat obesity, metabolic diseases and other gastrointestinal disorders, today ... Thursday, August 6, 2015, at 11:00 AM Eastern Time ... June 30, 2015, and to provide an update on ... via the Maestro® System. Conference Call Details ...
(Date:7/30/2015)... 2015 Tissue Regenix Group ... medical devices company, announces that it has further ... market as Tissue Regenix Wound Care Inc. has ... First Coast Service Options Inc. ("First Coast") whose ... Puerto Rico and the US ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results 2EnteroMedics to Host Second Quarter 2015 Financial Results and Company Update Conference Call 2EnteroMedics to Host Second Quarter 2015 Financial Results and Company Update Conference Call 3Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 2Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 3
... , , , , , , ... MIVI-TRUST Phase III Program With Microplasmin Recruits a Total of Over,640 ... (Euronext Brussels: THR), a biopharmaceutical company,focused on the discovery and development ... that it has completed,the enrolment of the second Phase III trial ...
... , NORCROSS, Ga., Dec. 15 Immucor, Inc. (Nasdaq: ... to the blood transfusion industry, today announced that it will ... 6, 2010 after the market close. The Company will host ... a.m. (Eastern Time) to discuss the results. , ...
Cached Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4
(Date:7/30/2015)... ... July 30, 2015 , ... ... at the annual All-Stars Summit. Google Partners is the platform for search marketing ... the full support and tools necessary to run successful search marketing campaigns. Google ...
(Date:7/30/2015)... ... , ... Quintessa Medical Spa is happy to offer patients the latest treatment ... for the elimination of excess tissue under the chin, referred to as submental fat. ... to offer this innovative treatment. , Developed by Kythera Biopharmaceuticals, Kybella was approved by ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American ... Chuck Rosenberg’s announcement of the reinstitution of National Prescription Drug Take-Back Days. The ... from 10:00 AM to 2:00 PM local time. On the 26th, the DEA, ...
(Date:7/30/2015)... Raleigh, NC (PRWEB) , ... July 30, 2015 , ... ... older patients. Click here to read more on the Surviving Mesothelioma website. ... Orthopedic Rehabilitation Hospital in Missouri reviewed more than 12,000 cases of mesothelioma occurring between ...
(Date:7/30/2015)... ... 30, 2015 , ... 1Heart Caregiver Services LLC is offering its 1st Business ... in the Booming Homecare Business.” This will be held in its main headquarters at ... event will be hosted by 1Heart’s very own Randy Clarito (Director of Business and ...
Breaking Medicine News(10 mins):Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:Upcoming Business Seminar at 1Heart Caregiver Services Headquarters Los Angeles California 2
... overeating, slothful horse leads to an obese horse. Unlike humans, ... obese horse. Caretakers may see no harm in giving their ... unhealthy as obesity in humans and can lead to fatal ... humans and horses when it comes to obesity," said Philip ...
... All India Institute of Medical Sciences (AIIMS) has developed ... cancer, underdeveloped genitals.// ,Doctors at the premier ... suffering from such problems, achieving 100 percent success. ... over 50 patients with not a single case of ...
... Divers scouring the sea-bed for abalone are paying with their ... while pursuing abalone, which is used in sushi// and a ... dollars apiece on the black market. ,Abalone are ... this mollusk is considered a delicacy in certain parts of ...
... Gulping down several litres of water to keep oneself cool ... won’t make much difference, warns scientists for marathon runners//. ... average runner will potentially lose almost a litre of sweat ... degrees, two degrees above normal. The sporting community has long ...
... called levodopa or L-dopa that helps in reviving cellular ... may experience motor complications and a reduced response to ... process of destruction of brain cells which produce dopamine. ... up as tremors in the arms, legs and face. ...
... and the possible reasons for them, a survey was ... revealed that present statistics of stillborns remained unchanged upon ... one in 200 pregnancies resulted in stillbirth, the survey ... Health (CEMACH) revealed that there were 3,600 ...
Cached Medicine News:Health News:Humans Aren't the Only Ones With Obesity Problems 2Health News:Artificial Testis Developed by AIIMS a Boon to Suffering Patients 2Health News:Hunt for Sea Delicacy Taking a Toll in California 2Health News:Hunt for Sea Delicacy Taking a Toll in California 3Health News:Large Fluid Intake Won’t Help to Keep Cool for Marathon Runner 2Health News:Stillbirth Figures Stand Still 2
Straight shafts with 1 x 2 teeth. Flat handle with haoles and polished finish. Delicate teeth. Most popular size or model....
Straight shafts with 0.12 mm teeth and 5 mm tying platform. Serrated handle with polished finish. Manufactured in titanium....
Straight shafts with polished finish. Teeth: 0.12 mm. Tying platform: 5.0 mm. Wide Serrated....
Straight shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Medicine Products: